Friday, May 1, 2026

Is Peace Between the U.S. and Iran Possible? Polymarket Predicts 57% Chance of Ceasefire!

Polymarket's predictions on U.S.-Iran ceasefire show its potential in data-driven decision-making amid Wall Street's growing interest.

5 MINUTES TO IMPACT: Kim’s Nuclear Cruise Missile Exposes US-Korea Defense Gap—A Strike Is Now INEVITABLE

North Korea tested a strategic cruise missile over the Yellow Sea, aiming to enhance its vertical launch capabilities against South Korea.

Discover the Excellence of Botulax and Revolax at Thailand’s Largest Dermatology Conference

Hugel showcased its HA filler Revolax and botulinum toxin products at Thailand's largest dermatology conference, enhancing medical engagement.

Tag: acquisitions

Eli Lilly vs. Novo Nordisk: A $1.2 Billion Bet Reveals Two Very Different Futures for Obesity Drugs

Eli Lilly and Novo Nordisk are pursuing different strategies in the obesity treatment market, focusing on expansion versus core strengths.

Big Pharma Braces for $300 Billion Loss as Blockbuster Drug Patents Expire

Global pharma faces $300B losses from patent expirations, prompting a shift to multi-indication drugs and innovative therapies.

Top News

- Our Sponsors Ad -

Follow us